Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
Open Access
- 23 May 2013
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 6 (6) , 689-699
Abstract
Dihydropyridine Ca2+ channel blockers (CCBs) are widely accepted in the treatment of premature labour. Their mechanism of action in tocolysis involves the blockade of L-type Ca2+ channels, influenced by the Ca2+-activated K+ channels, beta-adrenergic receptors (β-ARs) and sexual hormones. In clinical practice, most experience has been gained with the use of nifedipine, whose efficacy is superior or comparable to those of β-agonists and oxytocin antagonists. Additionally, it has a favourable adverse effect profile as compared with the majority of other tocolytics. The most frequent and well-tolerated side-effects of CCBs are tachycardia, headache and hypotension. In tocolytic therapy efforts are currently being made to find combinations of tocolytic agents that yield better therapeutic action. The available human and animal studies suggest that the combination of CCBs with β-AR agonists is beneficial, although such combinations can pose risk of pulmonary oedema in multiple pregnancies and maternal cardiovascular diseases. Preclinical data indicate the potential benefit of combinations of CCBs and oxytocin antagonists. However, the combinations of CCBs with progesterone or cyclooxygenase inhibitors may decrease their efficacy. The CCBs are likely to remain one of the most important groups of drugs for the rapid inhibition of premature uterine contractions. Their significance may be magnified by further clinical studies on their combined use for tocolysis.Keywords
This publication has 64 references indexed in Scilit:
- Tocolytic therapy for preterm delivery: systematic review and network meta-analysisBMJ, 2012
- Nifedipine Versus Ritodrine for Suppression of Preterm Labor and Analysis of Side EffectsThe Journal of Obstetrics and Gynecology of India, 2011
- Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm laborInternational Journal of Gynecology & Obstetrics, 2011
- Modification of the effect of nifedipine in the pregnant rat myometrium: The influence of progesterone and terbutalineLife Sciences, 2009
- ACOG Committee Opinion No. 419: Use of Progesterone to Reduce Preterm BirthObstetrics & Gynecology, 2008
- The relaxant effect of nifedipine in human uterine smooth muscle and the BKCa channelAmerican Journal of Obstetrics and Gynecology, 2008
- Progesterone and the Risk of Preterm Birth among Women with a Short CervixNew England Journal of Medicine, 2007
- Nifedipine serum levels in pregnant women undergoing tocolysis with nifedipineJournal of Obstetrics and Gynaecology, 2007
- Acute pulmonary edema during tocolytic therapy with nifedipineAmerican Journal of Obstetrics and Gynecology, 2006
- Atosiban and nifedipin for the treatment of preterm laborInternational Journal of Gynecology & Obstetrics, 2005